Growth Metrics

Catalyst Pharmaceuticals (CPRX) Leases (2019 - 2025)

Historic Leases for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to $2.0 million.

  • Catalyst Pharmaceuticals' Leases fell 1264.67% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 1264.67%. This contributed to the annual value of $2.2 million for FY2024, which is 1108.45% down from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Leases is $2.0 million, which was down 1264.67% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Leases ranged from a high of $3.3 million in Q1 2021 and a low of $2.0 million during Q3 2025
  • Moreover, its 5-year median value for Leases was $2.6 million (2023), whereas its average is $2.6 million.
  • Its Leases has fluctuated over the past 5 years, first soared by 2532122.13% in 2021, then plummeted by 1264.67% in 2025.
  • Catalyst Pharmaceuticals' Leases (Quarter) stood at $3.0 million in 2021, then fell by 8.19% to $2.8 million in 2022, then dropped by 9.46% to $2.5 million in 2023, then fell by 11.08% to $2.2 million in 2024, then decreased by 9.87% to $2.0 million in 2025.
  • Its Leases stands at $2.0 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.2 million for Q1 2025.